Pfizer's Center for Therapeutic Innovation is seeking proposals for the advancement of RNA therapeutics and the development of the next generation of RNA medicines.
Submissions are invited for novel target concepts and therapeutic strategies amenable to RNA based approaches (mRNA, circular RNA, gene editing) in the areas of cellular reprogramming, cancer vaccines, infectious disease vaccines, kidney diseases, rare liver and neuromuscular diseases, and repeat expansion diseases, among others.
Please develop a 2-3 page non-confidential document outlining the scientific background and research synopsis. Faculty interested in submitting a project should contact [email protected] The deadline to submit pre-proposals via email to [email protected] is April 6, 2022. Please see this link for pre-proposal template and additional details.